Kiyatec Inc.

Kiyatec Inc.

生物技术研究

Greenville,SC 2,700 位关注者

Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins

关于我们

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and the NCI. We are conducting robust clinical trials to fully demonstrate the power of our approach and earn widespread adoption for a broad portfolio of products predicting response to today’s and tomorrow’s therapies. www.kiyatec.com

网站
https://www.kiyatec.com
所属行业
生物技术研究
规模
11-50 人
总部
Greenville,SC
类型
私人持股
创立
2010
领域
3D Cell Culture Technologies、High Content Drug Discovery、Personalized Cancer Diagnostics、Contract Research Organization (CRO)、Preclinical Drug Development、Drug Response Profiling、Oncology Drug Response Profiling、Oncology Drug Screening和Immune Oncology

地点

Kiyatec Inc.员工

动态

相似主页

查看职位